Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Kindred Biosciences, Inc. (KIN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/30/2021 8-K Quarterly results
08/26/2021 8-K Quarterly results
08/02/2021 8-K Other Events  Interactive Data
06/16/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER",
"FORM OF SUPPORT AGREEMENT",
"Elanco Announces Agreement to Acquire Kindred Biosciences Bolt-on Acquisition Accelerates Elanco’s Expansion in Pet Health"
06/02/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
04/20/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
02/09/2021 8-K Quarterly results
02/01/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/11/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
12/07/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/25/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/20/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/09/2020 8-K Quarterly results
Docs: "Kindred Biosciences Announces Third Quarter 2020 Financial Results"
10/07/2020 8-K Quarterly results
09/16/2020 8-K Other Events  Interactive Data
08/05/2020 8-K Quarterly results
06/17/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "KINDRED BIOSCIENCES, INC. 2018 EQUITY INCENTIVE PLAN, AS AMENDED"
06/08/2020 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
05/20/2020 8-K Other Events  Interactive Data
05/12/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
04/15/2020 8-K Completion of Acquisition or Disposition of Assets
Docs: "Kindred Biosciences Announces Completion of Mirataz ® Transaction San Francisco, California"
04/08/2020 8-K Entry into a Material Definitive Agreement
Docs: "Opinion of TroyGould PC",
"At The Market Offering Agreement, between Kindred Biosciences, Inc. and H.C. Wainwright & Co., LLC"
03/16/2020 8-K Quarterly results
Docs: "Asset Purchase Agreement between Kindred Biosciences, Inc. and Dechra Limited. (Schedules and exhibits to the Asset Purchase Agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K but will be furnished to the Securities and Exchange Commission upon its request.)",
"First Amendment to Loan and Security Agreement among Kindred Biosciences, Inc., KindredBio Equine, Inc., Centaur Biopharmaceutical Services, Inc., Solar Capital, Ltd., as collateral agent and lender, and the other lenders named therein",
"Kindred Biosciences Announces Mirataz ® Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results San Francisco, California"
01/13/2020 8-K Investor presentation
Docs: "Kindred Biosciences, Inc. Investor Presentation"
12/09/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Investors"
11/12/2019 8-K Quarterly results
10/02/2019 8-K Quarterly results
08/01/2019 8-K Quarterly results
Docs: "Kindred Biosciences Announces Second Quarter 2019 Financial Results and Unveils Positive Results from Pilot Efficacy Study of Parvovirus Monoclonal Antibody – Mortality benefit seen in both prophylaxis and treatment of parvovirus infection San Francisco, California"
07/29/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for the Treatment of Atopic Dermatitis in Dogs - Achieved rapid and dramatic reduction in pruritus and CADESI score versus placebo. - Call to discuss study results at 8:30 a.m. Eastern time today. San Francisco, California"
06/26/2019 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy